You are here

Article Text

Article menu

Download PDFPDF

Cardiac risk factors and prevention
Original research
Cardiac rehabilitation for heart failure and atrial fibrillation: a propensity- matched study
  1. Munyra Alhotye1,2,
  2. Rachael Evans1,3,
  3. Andre Ng4,5 and
  4. Sally J Singh1,3
  1. 1Department of Respiratory Sciences, University of Leicester, Leicester, UK
  2. 2Department of Respiratory Therapy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  3. 3Centre for Exercise and Rehabilitation Science, University Hospitals of Leicester NHS Trust, Leicester, UK
  4. 4Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
  5. 5Department of Cardiovascular Sciences, NIHR Leicester Biomedical Research Centre, Leicester, UK
  1. Correspondence to Ms Munyra Alhotye; ma880{at}leicester.ac.uk

Abstract

Background Atrial fibrillation (AF) is common in individuals with heart failure (HF). Individuals with HF and AF may have a reduced functional capacity and quality of life (QoL) which leads to hospital admission and burden on clinical services. Evidence supported the effect of exercise training in individuals with HF. However, there is no existing data on the effectiveness of comprehensive cardiac rehabilitation (CR) in individuals with coexisting HF and AF.

Aim To explore the effect of CR in individuals with HF and AF compared with those with HF and no-coexisting AF.

Methods Using CR database, individuals with HF and AF were identified and propensity matched to those with no coexisting AF. The change in incremental shuttle walking test, Heart Disease Quality of Life questionnaire, Hospital Anxiety and Depression Scores were compared between groups pre-CR and post-CR.

Results 149 individuals were propensity matched from each group. The mean±SD age of the matched sample was 73.4±8 years, body mass index 29±5.5 kg/m2, left ventricular ejection fraction 35.2±9.8% and 56% were male.

A statistically significant improvements in exercise capacity, heart disease QoL, anxiety and depression scores were observed within each group. There were no significant differences between groups for any of these outcome measures.

Conclusions Individuals with HF and AF gain a similar improvement in exercise capacity and health related QoL outcomes as individuals with no coexisting AF following CR. The presence of AF did not compromise the effectiveness of CR.

  • CARDIAC REHABILITATION
  • HEART FAILURE
  • Atrial Fibrillation

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information. Request for the data use can be made to the study principal investigator Professor. Sally J Singh; e-mail: Sally.singh@uhl-tr.nhs.uk.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/openhrt-2023-002372

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    WHAT IS ALREADY KNOWN ON THIS TOPIC

    • Cardiac rehabilitation (CR) is effective programme in improving clinical outcomes and exercise capacity in individuals with cardiac diseases.

    • Evidence supported the effect of exercise training in individuals with heart failure (HF). However, there is no existing data on the effectiveness of comprehensive CR in individuals with coexisting HF and atrial fibrillation (AF).

    WHAT THIS STUDY ADDS

    • Individuals with HF and AF gain a similar improvement in exercise capacity and health related quality of life (QoL) outcomes as individuals with no coexisting AF after CR.

    • The presence of AF did not compromise the effectiveness of CR for those with HF.

    HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

    • We believe that CR could be an effective intervention to manage individuals with coexisting AF by improving their clinical outcomes and exercise capacity.

    • In turn, this could improve QoL and reduce future cardiovascular events.

    Introduction

    Atrial fibrillation (AF) is considered the most common type of cardiac arrhythmias (irregular heart beat) that occur in ageing population.1 In addition to age, chronic diseases such as heart failure (HF) are associated with development of AF.2 3 The prevalence of AF among individuals with HF is about 10%–30%, whereas in severe HF cases with reduced ventricular ejection fraction (EF<35%) and New York Heart Association (NYHA) functional class (≤II), it presents more often.4 The development of AF in individuals with HF is correlated with an increase risk of stroke and other cardiovascular events which leads to increased hospitalisation and mortality.5

    The common symptoms associated with AF are palpitations, chest pain, breathlessness, fatigue, dizziness, diaphoresis, sleep disturbance, exercise intolerance that could result in reduced functional capacity and impaired quality of life (QoL).6–9 Individuals living with AF can experience anxiety and depression. Inevitably, there is a huge burden of this condition to both the individuals, in terms of reduced QoL, and to the community in terms of medical services and costs of care. It has been estimated that AF- related medical services to the National Health Services (NHS) is in the region of £1.9 billion annually, with additional clinical services cost of total £329 million.10

    The management of AF has been catalogued in different international and national organisational guidelines including the National Institute for Health and Care Excellence and European Society of Cardiology.11 12 The outlined management plans of these guidelines concentrated mainly on pharmacological treatments, or invasive medical interventions such as catheter ablation procedure to control heart rate and maintain normal sinus rhythm, reduce symptoms, cardiovascular and thromboembolic complications related to the disease.

    Despite the positive effect of current AF treatments in managing heart arrhythmia, reducing risk of stroke and disease related symptoms, they do not focus on improving exercise capacity and health related quality of life (HRQoL) which are commonly reduced in individuals with AF.

    Cardiac rehabilitation (CR) is a multidisciplinary comprehensive programme targeting individuals with cardiovascular diseases. The programme includes patient assessment, education, individualised exercise training, behaviour modification and risk factor management.13 A meta-analysis conducted by Taylor et al included 13 randomised clinical trials, indicated that exercise training alone is a beneficial intervention on improving exercise capacity assessed by 6 min walking test and QoL in individuals with HF with reduced EF.14 In addition, a recent systematic review supported the positive effect of exercise training on both exercise capacity and HRQoL in individuals with AF.15 There is a constant guidance on the delivery of CR to those with HF, but these recommendation does not extend to those with AF or those with combined disease.12 16

    Despite the current evidence supporting the programme as an effective intervention for individuals with HF or AF, there is a lack of real-world data on the effectiveness of CR in individuals with HF with a documented diagnosis of AF. Therefore, the aim of this study was to compare the effect of supervised outpatient CR programme in individuals with HF and AF compared with a matched control group of those with no coexisting AF.

    Methods

    Participants

    We performed a retrospective analysis of data collected from individuals with HF who enrolled into the CR programme at Glenfield Hospital, University Hospitals of Leicester NHS Trust between January 2015 and February 2020. Inclusion criteria included individuals with a confirmed diagnosis of HF determined by Cardiac Physician, with documented evidence of AF and low ventricular EF (<50%), those with no documented evidence of coexisting AF were considered as a control group. Those who enrolled into the programme underwent an individual clinical assessment. Baseline outcome measures were assessed including measurements of the body mass index (BMI), Hospital Anxiety and Depression Score (HADS),17 Heart Disease Health Related Quality of Life (MacNew) questionnaire18 and the incremental shuttle walking test (ISWT),19 which is a valid and reliable field test used to assess cardiopulmonary fitness.

    The MacNew questionnaire contains 27 items which categorised into three domains: physical limitations domain, emotional function and social function domain scales. There are also five items that asking about disease symptoms including: chest pain, fatigue, shortness of breath, dizziness and legs pain in the previous 2 weeks. The maximum expected score in each domain is seven which considered a high HRQoL, and the minimum possible score is one which considered a low HRQoL.

    Measures of BMI, ISWT, HADS and MacNew questionnaires were repeated after the completion of CR programme.

    CR programme

    The CR programme was a comprehensive 6-week outpatient programme delivering two supervised sessions a week (total of 12 sessions) supervised by qualified physiotherapists and nurses. The supervised sessions consisted of 1 hour of exercise training and 45–60 min of educational session. The exercise training consisted of aerobic exercises (walking, cycling and treadmill walking), and resistance exercise (free weight lifting, step ups, upper and lower body strength training). Intensity of these exercises was individually tailored. The educational sessions were delivered by a qualified multidisciplinary team. The sessions offered specific topics to enhance individuals understanding of their disease and how they manage their symptoms. It also focuses on the importance of exercise and physical activity, medication use, nutritional advice and self-management plans. An additional home-exercise session to be completed independently each week.

    The programme was conducted according to the British Association for Cardiovascular Prevention and Rehabilitation standards and the Association for Charted Physiotherapists in Cardiovascular Rehabilitation guidelines.20

    Data analysis

    Data analyses were performed using the SPSS V.25.0 and Prism V.7.0.21 22 Analyses was initially descriptive which is presenting of means and SD. Paired t-tests or Wilcoxon signed-rank tests were used to compare clinical outcome measures before and after CR within groups and independent t-test or Mann-Whitney tests were used to compare between groups. P value of <0.05 represented a statistically significant improvement.

    Propensity score matching was conducted using R program V.3.0.3 between individuals with HF and AF compared with HF individuals with no coexisting AF.23 MatchIt package was installed to perform a 1:1 nearest-neighbour propensity score matching using age, gender, BMI and left ventricular ejection fraction (LVEF).

    Individuals enrolled in CR provided an informed consent to participate into the programme and for their data to be recorded and used anonymously for clinical evaluation and audit purposes. As per guidelines from the NHS Health Research Authority, this study did not require an ethical approval as it considered as a part of clinical audit.

    Results

    Between January 2015 and March 2020, 783 individuals with a primary diagnosis of HF were referred to our CR programme. Two hundred and ninety-nine of these individuals were excluded from our study due to missing reported measures. The resulting 484 individuals were divided into two groups: (1) individuals with HF and AF; (2) individuals with no coexisting AF. Medical history data including risk factors, comorbidities and previous cardiac events were collected from individuals medical records.

    A total of 149 individuals with HF and AF were matched 1:1 to the nearest individuals with no coexisting AF. Baseline characteristics of gender, age, LVEF and NYHA classification for both groups are displayed in table 1. Both groups were well matched based on their age, gender, BMI and LVEF, the distributions of propensity score matching are shown in figure 1. There was no significant difference between groups in those measures. However, in individuals with HF and AF, the LVEF was lower than individuals with no coexisting AF (table 1).

    Figure 1
    Figure 1

    Distribution of propensity scores.

    View this table:
    Table 1

    Baseline characteristics of groups prior to matching

    For the matched individuals, each group made a significant improvement in exercise capacity (ISWT), HRQoL (MacNew overall score), HADS after successfully completing the programme (table 2). There were no differences found in levels of HRQoL, exercise capacity, anxiety and depression between groups. However, baseline exercise capacity (ISWT) was less in the group with coexisting AF (235±137) (table 2, figure 2).

    Figure 2
    Figure 2

    Response of (A) incremental shuttle walk (ISW) distance and (B) MacNew questionnaire—total score to cardiac rehabilitation (CR). AF, atrial fibrillation; MacNew, Heart Disease Health Related Quality of Life.

    View this table:
    Table 2

    Clinical outcome measures of two matched groups at baseline and after cardiac rehabilitation

    Discussion

    To the best of our knowledge, this is the first study to assess the benefits of a comprehensive CR programme in individuals with HF and coexisting AF compared with those with no coexisting AF using real-life data.

    AF frequently coexists in individuals with HF, and there are no data to describe the effect of comprehensive rehabilitation programme in individuals with coexisting disease. In this real-life propensity-matched study, we investigated the effect of CR in HF individuals living with AF compared with those with no coexisting AF. Our study found that individuals with HF and AF had a significant improvement in clinical outcomes following completion of 6 week outpatient supervised CR. Despite a lower baseline levels of exercise capacity, we found that these improvements are similar to those matched control group of individuals with no coexisting AF.

    Our data found that exercise capacity significantly improved following rehabilitation programme when assessed by ISWT. This show an early benefit from enrolling into the programme for those with coexisting AF. Although the baseline measures of exercise capacity were lower in this group, they show a meaningful improvement after completing the programme which exceeded the minimal clinical important difference for this population.24 These findings are consistent with previous randomised clinical trials that examined the positive effect of exercise training in individuals with HF.25 Although the previous data did not include those with coexisting AF, the improvements in exercise capacity were reported in another review investigating the positive effect of exercise training in individuals with AF.26–28 Our results demonstrated that the added burden of AF does not compromise the outcomes of CR.

    Levels of anxiety and depression were assessed at baseline and after completion of the programme using the HADS scale.29 This validated scale has been used extensively in individuals with cardiovascular disease including AF.30 31 In our study, there were no difference in baseline scores of anxiety or depression between the two groups. Interestingly, the values are within the normal range. In addition, there was no between group difference in the scores postrehabilitation programme, but we observed a within group difference in those with coexisting AF. However, there is a lack of clinical data describing the psychological benefits of rehabilitation programmes in these population, and was not represented in the previous systematic review.15

    In our analysis, we observed no important difference in gains of HRQoL between the two groups, but a significant clinical improvement were made within each group in overall HRQoL scores when assessed by MacNew questionnaire. In a previous observational study conducted by Hegbom et al,28 they reported that short-term exercise training programme would result in a statistical significant improvement in HRQoL in individuals with chronic AF measured by Short-Form 36.28 Improvement in HRQoL has also been shown after exercise training programme in individuals with HF.32 However, it is difficult to compare data because these clinical studies did not offer a comprehensive CR programme and the quality of data was low.

    Our findings are important as individuals with HF with coexisting AF could benefit from a comprehensive rehabilitation programme and should not be excluded from CR.

    Strengths and limitations

    A propensity score matching was used as a formal statistical technique to ensure the similarity of baseline characteristics between groups, and the analysis included those who completed the programme with data collected pre-rehabilitation and postrehabilitation programme. Several factors must be addressed when interpreting the results. First, a propensity matching method was used in order to reduce the potential bias between the study groups. However, it may not completely eliminate this bias. Second, the data were pooled from a single centre which may affect the generalisability of our findings. Another key limitation is that the study cohort included only those who completed the programme without assessing those who did not complete the programme. Also, the small sample size and characteristics of the cohort could impact the applicability of the findings to other population.

    Future work

    Additional studies including large randomised controlled trails are needed to confirm and support these findings. Moreover, a long-term follow-up assessments would highlight the long-term viability of these improvements and the impact on clinical outcomes such as hospitalisation and mortality rate.

    This study suggests that comprehensive CR programmes can significantly improve exercise capacity, QoL and psychological well-being for individuals with HF and coexisting AF. However, it is important to consider the study’s limitations and await further research to fully understand CR’s benefits and its long-term effects in this population.

    Conclusion

    This propensity matched study demonstrated that individuals with HF and coexisting AF have gained a significant improvement in exercise capacity, HRQoL, HADS after completion of a comprehensive CR programme. There was no significant difference in the HF group with coexisting AF compared with those with no coexisting AF. This supports the positive effect of rehabilitation programme as a promising therapeutic intervention for improving clinical measures in individuals with HF and coexisting AF.

    Data availability statement

    All data relevant to the study are included in the article or uploaded as supplementary information. Request for the data use can be made to the study principal investigator Professor. Sally J Singh; e-mail: Sally.singh@uhl-tr.nhs.uk.

    Ethics statements

    Patient consent for publication

    Acknowledgments

    SS is a National Institute for Health Research (NIHR) senior investigator. This work is supported by the NIHR Leicester Biomedical Research Centre (BRC)-Respiratory, and it was presented as an abstract in the British Association for Cardiovascular Prevention and Rehabilitation (BACPR) Annual Conference in October 2022. (Alhotye, M., Gardiner, N., Evans, R., Ng, A., & Singh, S. J. (2022). 14 Cardiac rehabilitation for heart failure and atrial fibrillation: a propensity-matched study). The views expressed are those of the author(s) and not necessarily those of NIHR or the Department of Health and Social Care.

    References

    1. ↵
      1. Furberg CD,
      2. Psaty BM,
      3. Manolio TA, et al
      . Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study). Am J Cardiol 1994;74:236–41. doi:10.1016/0002-9149(94)90363-8
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      1. Shukla A,
      2. Curtis AB
      . Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression. Vasc Health Risk Manag 2014;10:1–12.:1. doi:10.2147/VHRM.S49334
      OpenUrlCrossRefPubMed
    3. ↵
      1. Lévy S
      . Factors predisposing to the development of atrial fibrillation. Pacing Clin Electrophysiol 1997;20(10 Pt 2):2670–4. doi:10.1111/j.1540-8159.1997.tb06115.x
      OpenUrlCrossRefPubMed
    4. ↵
      1. Neuberger H-R,
      2. Mewis C,
      3. van Veldhuisen DJ, et al
      . Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568–77. doi:10.1093/eurheartj/ehm341
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      1. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery,
      2. Camm AJ, et al
      . Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Eur Heart J 2010;31:2369–429. doi:10.1093/eurheartj/ehq278
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      1. Kirchhof P,
      2. Benussi S,
      3. Kotecha D, et al
      . ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50:e1–88. doi:10.1093/ejcts/ezw313
      OpenUrlCrossRefPubMed
    7. ↵
      1. Rienstra M,
      2. Lubitz SA,
      3. Mahida S, et al
      . Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation 2012;125:2933–43. doi:10.1161/CIRCULATIONAHA.111.069450
      OpenUrlFREE Full Text
    8. ↵
      1. Brundel BJJM,
      2. Ai X,
      3. Hills MT, et al
      . Atrial fibrillation. Nat Rev Dis Primers 2016;2:16017. doi:10.1038/nrdp.2016.17
      OpenUrl
    9. ↵
      1. Reed JL,
      2. Terada T,
      3. Chirico D, et al
      . The effects of cardiac rehabilitation in patients with atrial fibrillation: A systematic review. Can J Cardiol 2018;34(10 Suppl 2):S284–95. doi:10.1016/j.cjca.2018.07.014
      OpenUrlCrossRefPubMed
    10. ↵
      1. Pink J,
      2. Lane S,
      3. Pirmohamed M, et al
      . Dabigatran Etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses. BMJ 2011;343:d6333. doi:10.1136/bmj.d6333
    11. ↵
      1. Perry M,
      2. Kemmis Betty S,
      3. Downes N, et al
      . Atrial fibrillation: diagnosis and management-summary of NICE guidance. BMJ 2021;373:1150. doi:10.1136/bmj.n1150
      OpenUrl
    12. ↵
      1. Hindricks G,
      2. Potpara T,
      3. Dagres N, et al
      . ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS) the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373–498. doi:10.1093/eurheartj/ehaa612
      OpenUrlCrossRefPubMed
    13. ↵
      1. Piepoli MF,
      2. Corrà U,
      3. Adamopoulos S, et al
      . Secondary prevention in the clinical management of patients with cardiovascular diseases. core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for cardiovascular prevention & rehabilitation. Eur J Prev Cardiol 2014;21:664–81. doi:10.1177/2047487312449597
      OpenUrlCrossRefPubMed
    14. ↵
      1. Taylor RS,
      2. Walker S,
      3. Smart NA, et al
      . Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol 2019;73:1430–43. doi:10.1016/j.jacc.2018.12.072
      OpenUrlCrossRefPubMed
    15. ↵
      1. Risom SS,
      2. Zwisler A-D,
      3. Johansen PP, et al
      . Exercise‐Based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev 2017;2:CD011197. doi:10.1002/14651858.CD011197.pub2
    16. ↵
      1. McDonagh TA,
      2. Metra M,
      3. Adamo M, et al
      . Corrigendum to: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure Association (HFA) of the ESC. Eur Heart J 2021;42:4901. doi:10.1093/eurheartj/ehab670
    17. ↵
      1. Zigmond AS,
      2. Snaith RP
      . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. doi:10.1111/j.1600-0447.1983.tb09716.x
      OpenUrlCrossRefPubMedWeb of Science
    18. ↵
      1. Höfer S,
      2. Lim L,
      3. Guyatt G, et al
      . The Macnew heart disease health-related quality of life instrument: a summary. Health Qual Life Outcomes 2004;2:3. doi:10.1186/1477-7525-2-3
    19. ↵
      1. Singh SJ,
      2. Morgan MD,
      3. Scott S, et al
      . Development of a shuttle walking test of disability in patients with chronic Airways obstruction. Thorax 1992;47:1019–24. doi:10.1136/thx.47.12.1019
      OpenUrlAbstract/FREE Full Text
    20. ↵
      1. Jones J,
      2. Buckley J,
      3. Furze G, et al
      . Cardiovascular prevention and rehabilitation in practice. In: Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation. 2020: 21–45. doi:10.1002/9781119071006
    21. ↵
      1. Corportation I
      . IBM SPSS Statistics for Windows (Version 25.0 Armonk). NY: IBM Corp, 2017.
    22. ↵
      1. Prism G
      . Software Graphpad software. n.d. Available: https://www. graphpad. com. RRID: SCR_002798
    23. ↵
      1. Team RC
      . A language and environment for statistical computing. R Foundation for Statistical Computing; 2013. Available: http://www. R-project. org
    24. ↵
      1. Houchen-Wolloff L,
      2. Boyce S,
      3. Singh S
      . The minimum clinically important improvement in the incremental shuttle walk test following cardiac rehabilitation. Eur J Prev Cardiol 2015;22:972–8. doi:10.1177/2047487314540840
      OpenUrlCrossRefPubMed
    25. ↵
      1. Jónsdóttir S,
      2. Andersen KK,
      3. Sigurosson AF, et al
      . The effect of physical training in chronic heart failure. Eur J Heart Fail 2006;8:97–101. doi:10.1016/j.ejheart.2005.05.002
      OpenUrlCrossRefPubMedWeb of Science
    26. ↵
      1. Risom SS,
      2. Zwisler A-D,
      3. Rasmussen TB, et al
      . Cardiac rehabilitation versus usual care for patients treated with catheter ablation for atrial fibrillation: results of the randomized CopenheartRFA trial. Am Heart J 2016;181:120–9. doi:10.1016/j.ahj.2016.08.013
      OpenUrlPubMed
    27. ↵
      1. Osbak PS,
      2. Mourier M,
      3. Henriksen JH, et al
      . Effect of physical exercise training on muscle strength and body composition, and their association with functional capacity and quality of life in patients with atrial fibrillation: a randomized controlled trial. J Rehabil Med 2012;44:975–9. doi:10.2340/16501977-1039
      OpenUrlCrossRefPubMed
    28. ↵
      1. Hegbom F,
      2. Sire S,
      3. Heldal M, et al
      . Short-term exercise training in patients with chronic atrial fibrillation: effects on exercise capacity, AV conduction, and quality of life. J Cardiopulm Rehabil 2006;26:24–9. doi:10.1097/00008483-200601000-00005
      OpenUrlCrossRefPubMed
    29. ↵
      1. Johnston M,
      2. Pollard B,
      3. Hennessey P
      . Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000;48:579–84. doi:10.1016/s0022-3999(00)00102-1
      OpenUrlCrossRefPubMedWeb of Science
    30. ↵
      1. Bambauer KZ,
      2. Locke SE,
      3. Aupont O, et al
      . Using the hospital anxiety and depression scale to screen for depression in cardiac patients. Gen Hosp Psychiatry 2005;27:275–84. doi:10.1016/j.genhosppsych.2005.03.002
      OpenUrlCrossRefPubMedWeb of Science
    31. ↵
      1. Ariansen I,
      2. Dammen T,
      3. Abdelnoor M, et al
      . Mental health and sleep in permanent atrial fibrillation patients from the general population. Clin Cardiol 2011;34:327–31. doi:10.1002/clc.20883
      OpenUrlCrossRefPubMed
    32. ↵
      1. Long L,
      2. Mordi IR,
      3. Bridges C, et al
      . Exercise‐Based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 2019;1:CD003331. doi:10.1002/14651858.CD003331.pub5

    Footnotes

    • Twitter @g_andre_ng

    • Contributors All authors have contributed to the design of the study, acquisition, data collection and analysis and interpretation of the data. The main author (MA), RE, AN and SS were involved in the design of the study. MA, SS and RE were involved in data collection and MA did the data analysis under supervision of SS, RE and AN. MA, RE and SS have been involved in drafting the work and revising it for important content and have given the final approval of the version published. The first author MA is responsible for the overall contents of this study.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.